IOMX THERAPEUTICS
iOmx Therapeutics focuses on the development of first-in-class cancer therapeutics addressing novel immune checkpoint modulators on tumor cells. By systematically screening human tumor cells, the Company has already identified a number of novel targets and analyzed their mode of action. The Company was founded on the successful concept of cancer immune-checkpoint therapy, which works by breaking down the inherent resistance mechanisms of tumors against immune attack. Immune resistance of tumors is often mediated by cell surface molecules that stimulate immune-inhibitory receptors on T cells. Reactivating the host immune response by neutralizing these negative interactions is the idea behind cancer immune-checkpoint therapy.
IOMX THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
Munich, Bayern, Germany
Country:
Germany
Website Url:
http://www.iomx.com
Total Employee:
11+
Status:
Active
Contact:
+49 (0)89 8999 7090 0
Email Addresses:
[email protected]
Total Funding:
105 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Domain Not Resolving Apache Mobile Non Scaleable Content PHP PHP 7 JQuery CDN GoDaddy SSL W3 Total Cache
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
MAGiQ Therapeutics
MAGiQ Therapeutics focuses on the development and licensing of regenerative medicine products generated from iPS cells.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sofinnova Partners
Sofinnova Partners investment in Series B - IOmx Therapeutics
MIG
MIG investment in Series B - IOmx Therapeutics
ATHOS Service
ATHOS Service investment in Series B - IOmx Therapeutics
M Ventures
M Ventures investment in Series B - IOmx Therapeutics
Wellington Partners
Wellington Partners investment in Series B - IOmx Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series A - IOmx Therapeutics
MPM Capital
MPM Capital investment in Series A - IOmx Therapeutics
Wellington Partners
Wellington Partners investment in Series A - IOmx Therapeutics
M Ventures
M Ventures investment in Series A - IOmx Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-03 | iOmx Therapeutics Appoints Dr. Murray Yule as CMO to Lead Clinical Development |
Official Site Inspections
http://www.iomx.com Semrush global rank: 4.81 M Semrush visits lastest month: 1.89 K
- Host name: 11.172.205.92.host.secureserver.net
- IP address: 92.205.172.11
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin
More informations about "IOmx Therapeutics"
iOmx Therapeutics
IOmx Therapeutics is a clinical-stage company that harnesses deep tumor and myeloid biology insights to generate novel treatments for the most prevalent solid tumor indications. ... build-up …See details»
IOM X - LEARN | ACT | SHARE TO STOP EXPLOITATION
IOM X is the International Organization for Migration's innovative campaign to encourage safe migration and public action to stop exploitation and human trafficking. The campaign is produced in partnership with the United States …See details»
IOmx Therapeutics - Crunchbase Company Profile & Funding
IOmx Therapeutics focuses on the development of first-in-class cancer therapeutics addressing novel immune checkpoint modulators on tumor cells. By systematically screening human …See details»
iOmx Therapeutics AG - LinkedIn
IOmx Therapeutics AG | 3,939 followers on LinkedIn. Developing next-generation targeted cancer immunotherapy treatments | iOmx is a young, dynamic start-up in the field of immuno-oncology located ...See details»
IOmx Therapeutics - Leadership Team - The Org
The Leadership Team at iOmx Therapeutics is responsible for setting the strategic direction of the company, overseeing the development and commercialization of innovative cancer …See details»
IOmx Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Oct 5, 2021 ... obfuscated. MIG …See details»
iOmx Therapeutics - VentureRadar
IOmx Therapeutics is a Munich-based biopharmaceutical company focused on developing first-in-class cancer immuno-therapeutics addressing novel immune checkpoints hijacked by cancer …See details»
IOM X FACTSHEET Human Trafficking - International Organization …
IOM X is the International Organization for Migration's (IOM) innovative campaign to encourage safe migration and public action to stop exploitation and human trafficking. The campaign is …See details»
iOmx Therapeutics
IOmx Therapeutics is a clinical-stage company that harnesses deep tumor and myeloid biology insights to generate novel treatments for the most prevalent solid tumor indications. The …See details»
IOM X eLearning
IOMX eLearning This short online course will provide you with an introduction to the different forms of exploitation and the techniques traffickers use. ... IOM X is the International …See details»
About - IOM X
IOM X is the International Organization for Migration’s (IOM) innovative campaign to encourage safe migration and public action to stop exploitation and human trafficking. The campaign …See details»
iOmx Therapeutics
IOmx is developing next-generation cancer immunotherapies designed to overcome the limitations of current treatments and become future backbone therapies for the most prominent solid …See details»
CONTACT - IOM X
IOM X is the International Organization for Migration’s innovative campaign to encourage safe migration and prevent human trafficking, funded by USAID.See details»
IOM X - LinkedIn
IOM X | 716 followers on LinkedIn. ABOUT US IOM X is the International Organization for Migration’s (IOM) innovative campaign to encourage safe migration and public action to stop …See details»
iOmx Therapeutics raises EUR 65 million in Series B round
Oct 5, 2021 iOmx Therapeutics (www.iomx.com) is a biopharmaceutical company focused on developing first-in-class cancer immunotherapies addressing novel immune checkpoints …See details»
iOmx Therapeutics — Sofinnova Partners
Sep 21, 2016 iOmx Therapeutics focuses on the development of first-in-class cancer therapeutics addressing novel immune checkpoint modulators on tumor cells. By …See details»
Blog - IOM X
Back in January, IOM X worked with an amazing youth-led organization called Project Liber8 on a human trafficking awareness-raising workshop with young YouTubers and media students …See details»
iOmx Therapeutics
IOmx is funded by an international consortium of leading life science investors. MIG Fonds; Sofinnova Partners; Wellington Partners; Merck Ventures; We discover and develop next …See details»
Hello from IOM X - IOM X
IOM X is the International Organization for Migration’s (IOM) innovative campaign to encourage safe migration and public action to stop human trafficking and exploitation. The campaign …See details»
IOM X - LEARN | ACT | SHARE TO STOP EXPLOITATION
Made was produced by IOM X, the International Organization for Migration (IOM) and the United States Agency for International Development’s (USAID) innovative campaign to encourage …See details»